GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Aodong Pharmaceutical Group Co Ltd (SZSE:000623) » Definitions » Net Change in Cash

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Net Change in Cash : ¥517 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Jilin Aodong Pharmaceutical Group Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Jilin Aodong Pharmaceutical Group Co's Net Change in Cash for the three months ended in Mar. 2024 was ¥-88 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥517 Mil.


Jilin Aodong Pharmaceutical Group Co Net Change in Cash Historical Data

The historical data trend for Jilin Aodong Pharmaceutical Group Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Aodong Pharmaceutical Group Co Net Change in Cash Chart

Jilin Aodong Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 275.72 296.13 -746.23 -304.55 281.75

Jilin Aodong Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -323.07 823.57 -80.35 -138.40 -87.96

Jilin Aodong Pharmaceutical Group Co Net Change in Cash Calculation

Jilin Aodong Pharmaceutical Group Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Jilin Aodong Pharmaceutical Group Co's Net Change in Cash for the quarter that ended in Mar. 2024


Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥517 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jilin Aodong Pharmaceutical Group Co Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Jilin Aodong Pharmaceutical Group Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Business Description

Traded in Other Exchanges
N/A
Address
No. 2158, Jidong Street, Dunhua, CHN, 133700
Jilin Aodong Pharmaceutical Group Co Ltd is engaged in manufacturing of pharmaceuticals. Its products include Anshen Bunao Liquid, Antelope Cough Syrup, Yangxue Yin Oral Liquid, Xinnao Shutong Capsule, Calf Spleen Extract Injection, Xuefu Zhuyu Oral Liquid, and others.
Executives
Guo Shu Qin Directors, executives
Wang Zhen Yu Directors, Directors, and Executives
Zhao Da Long Director
Yang Kai Directors, executives
Li Xiu Lin Director
Zhang Shu Yuan Directors, executives
Chen Yong Feng Supervisors
Zhang Ming Jing Supervisors
Li An Ning Supervisors
Lin Xiao Lin Executives
Ying Gang Director
Guo Li Supervisors
Xu Dong Lin Supervisors
Zhu Yan Directors, executives
Li Li Ping Supervisors

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Headlines

No Headlines